27.51MMarket Cap
LossP/E TTM
Key Figures
6.000Open
6.220High
21.76KVolume
LossP/E TTM
12.80P/E Dynamic
--Dividend TTM
0.48%Turnover Ratio
6.090Prev. Close
6.000Low
116.04KTurnover
LossP/E Static
2.74P/B
0.00%Div Yield TTM
-12.41%ROA
9.45852wk High
2.15Volume Ratio
-12.40MNet Profit
4.51MShares
-2.1224EPS TTM
1.55Beta
-78.65%ROE
3.10152wk Low
3.61%Amplitude
55.04%Gross Margin
27.51MMarket Cap
-0.83Reward/Risk
4.93%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Harvard Bioscience Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 106 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Harvard Bioscience Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Harvard Bioscience Inc Highlights
StrengthsRisks
Harvard Bioscience Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Harvard Bioscience Inc
HBIO
2
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Harvard Bioscience Inc Info
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
Ticker SymbolHBIO
CompanyHarvard Bioscience Inc
CEODuke (John D)
Websitehttps://www.harvardbioscience.com/
Shareholders
FAQs
What is the current price of Harvard Bioscience Inc (HBIO)?
The current price of Harvard Bioscience Inc (HBIO) is 6.21.
What is the symbol of Harvard Bioscience Inc?
The ticker symbol of Harvard Bioscience Inc is HBIO.
What is the 52-week high of Harvard Bioscience Inc?
The 52-week high of Harvard Bioscience Inc is 9.46.
What is the 52-week low of Harvard Bioscience Inc?
The 52-week low of Harvard Bioscience Inc is 3.10.
What is the market capitalization of Harvard Bioscience Inc?
The market capitalization of Harvard Bioscience Inc is 28.01M.
Is Harvard Bioscience Inc (HBIO) currently rated as Buy, Hold, or Sell?
According to analysts, Harvard Bioscience Inc (HBIO) has an overall rating of Buy, with a price target of 6.00.
What is the Earnings Per Share (EPS TTM) of Harvard Bioscience Inc (HBIO)?
The Earnings Per Share (EPS TTM) of Harvard Bioscience Inc (HBIO) is -12.77.
